MDM2 and colorectal cancer: Inhibition of LUCAT1 binding to UBA52 and activation of the UBA52-MDM2-p53 pathway in colorectal cancer knockout mice had significantly elevated expression in colorectal cancer and inhibited colorectal cancer development [21].